[Asia Economy Reporter Ji Yeon-jin] Access Bio announced on the 23rd that its consolidated sales last year reached 505.1 billion KRW, an increase of 314.7% compared to the previous year.


During this period, operating profit rose 278.6% to 260.1 billion KRW, and net profit increased 297.4% to 189.9 billion KRW.



The company stated, "Sales and operating profit increased significantly due to the expansion of sales of COVID antigen diagnostic products and self-diagnostic kits."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing